"Actually, it has been conveyed for the needs of corporations and additional capital for SOEs or institutions assigned for corporate underwriting," Isa Rachmatarwata said at a hearing meeting with Commission XI of the Indonesian Parliament in Jakarta on Monday.
He said this was done through the issuance of a decree by the Minister of Finance — KMK No.500 / 2020 — which was only enacted last week.
Rachmatarwata informed that the additional PMN allocation of Rp1.57 trillion will be made to PT Penjaminan Infrastruktur Indonesia, or PII (Persero); Rp2 trillion to PT Bio Farma (Persero); and, Rp5 trillion to the Indonesian Export Financing Agency (LPEI).
"We plan to add state capital participation for LPEI and PII because both have been asked to carry out underwriting for corporations," he explained.
Related news: BUMN, one institution allotted Rp42.38 trillion from Finance Ministry
Meanwhile, he said, the additional allocation for Bio Farma was originally planned for next year, but due to pressing requirements such as vaccine development, it was accelerated.
“The (fund injection) plan was for 2021, but because there is a need to accelerate it, the plan will be updated," he remarked.
Earlier on November 6, 2020, Rachmatarwata had explained that the funds injection for Bio Farma was being carried out in the context of procuring drugs, COVID-19 vaccines, and developing health infrastructure.
The PMN will be given entirely to Bio Farma and the government has handed it the authority to determine how to distribute the funds to PT Kimia Farma Tbk and PT Indonesia Farma Tbk.
"We are adding it to the 2020 State Budget because it is relevant to handling COVID-19," he stated.
Related news: President calls for accountable, precise handling of COVID-19 funds
Related news: COVID-19 handling costs equivalent to 4.2 percent of GDP: Minister
Translator: Astrid Habibah, Azis Kurmala
Editor: Yuni Arisandy Sinaga
Copyright © ANTARA 2020
